Aristotle Capital Management, LLC Abbott Laboratories Transaction History

Aristotle Capital Management, LLC

$51.7 Billion
Q3 2024

A detailed history of Aristotle Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Aristotle Capital Management, LLC holds 54,757 shares of ABT stock, worth $6.21 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,757

Previous 54,757 -0.0%

Holding current value

$6.21 Million

Previous $5.69 Million 9.72%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $32,856 - $36,288	-300 Reduced 0.54%	54,757 $6.22 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $145,205 - $177,744	-1,610 Reduced 2.84%	55,057 $6.06 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $782,758 - $872,156	-7,767 Reduced 12.05%	56,667 $6.18 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $877,551 - $1.03 Million	-9,060 Reduced 12.33%	64,434 $6.52 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $48,380 - $56,015	-500 Reduced 0.68%	73,494 $7.11 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $15,310 - $18,505	-150 Reduced 0.2%	73,994 $8.04 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $18,243 - $22,246	-160 Reduced 0.22%	74,144 $8.78 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $45,518 - $55,735	-394 Reduced 0.53%	74,304 $10.5 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $104,994 - $116,154	-900 Reduced 1.19%	74,698 $8.82 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $148,106 - $174,342	-1,400 Reduced 1.82%	75,598 $8.76 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $27,210 - $32,057	-250 Reduced 0.32%	76,998 $9.23 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $1,260 - $1,373	-12 Reduced 0.02%	77,248 $8.46 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $824 - $1,001	9 Added 0.01%	77,260 $8.41 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $57,121 - $73,108	746 Added 0.98%	77,251 $7.06 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $62,380 - $91,216	-993 Reduced 1.28%	76,505 $6.04 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $2,041 - $2,272	-26 Reduced 0.03%	77,498 $6.73 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $308,782 - $334,816	-3,773 Reduced 4.64%	77,524 $6.49 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $551,993 - $643,790	-7,574 Reduced 8.52%	81,297 $6.84 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $27,746 - $33,545	-419 Reduced 0.47%	88,871 $7.1 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $11,128 - $13,424	183 Added 0.21%	89,290 $6.55 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $69,155 - $78,188	-1,229 Reduced 1.36%	89,107 $5.34 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $65,972 - $70,630	1,229 Added 1.38%	90,336 $5.16 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $14,610 - $16,306	304 Added 0.34%	89,107 $4.76 Million
Q2 2017 Nov 16, 2017	SELL	N/A	-6,800 Reduced 7.11%	88,803 $4.32 Million
Q1 2017 Nov 16, 2017	SELL	N/A	-229 Reduced 0.24%	95,603 $4.25 Million
Q4 2016 Nov 16, 2017	SELL	N/A	-2,600 Reduced 2.64%	95,832 $3.68 Million
Q3 2016 Nov 16, 2017	SELL	N/A	-4,737 Reduced 4.59%	98,432 $4.16 Million
Q2 2016 Nov 16, 2017	SELL	N/A	-550 Reduced 0.53%	103,169 $4.06 Million
Q1 2016 Nov 17, 2017	SELL	N/A	-1,050 Reduced 1.0%	103,719 $4.34 Million
Q4 2015 Nov 16, 2017	SELL	N/A	-250 Reduced 0.24%	104,769 $4.71 Million
Q3 2015 Nov 16, 2017	BUY	N/A	105,019	105,019 $4.22 Million

Others Institutions Holding ABT

# of Institutions

3,196

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Management, LLC with notifications on news.

Account

Aristotle Capital Management, LLC Abbott Laboratories Transaction History